Currently out of the existing stock ratings of Colleen Kusy, 71 are a BUY (89.87%), 8 are a HOLD (10.13%).

Colleen Kusy

Work Performance Price Targets & Ratings Chart

Analyst Colleen Kusy, currently employed at BAIRD, carries an average stock price target met ratio of 49.62% that have a potential upside of 38.47% achieved within 161 days.

Colleen Kusy’s has documented 152 price targets and ratings displayed on 15 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on ARGX, argenx NV ADR at 27-Jul-2026.

Wall Street Analyst Colleen Kusy

Analyst best performing recommendations are on NUVL (NUVALENT).
The best stock recommendation documented was for NUVL (NUVALENT) at 9/10/2024. The price target of $105 was fulfilled within 6 days with a profit of $17.51 (20.01%) receiving and performance score of 33.36.

Average potential price target upside

OCS Oculis Holding AG Ordinary shares AGEN Agenus APLS Apellis Pharmaceuticals ARGX argenx NV ADR CHRS Coherus BioSciences COGT Cogent Biosciences ELVN Enliven Therapeutics IOVA Iovance Biotherapeutics ISEE IVERIC bio NUVL Nuvalent OCUL Ocular Therapeutix SURF Surface Oncology SYRE Spyre Therapeutics MRSN Mersana Therapeutics SABS SAB Biotherapeutics

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 12-Jun-2023

$39

$30.66 (367.63%)

25 days ago
(18-Sep-2026)

15/24 (62.5%)

$28.86 (284.62%)

650

Buy Since 19-Dec-2025

$20

$11.66 (139.81%)

$23

1 months 29 days ago
(14-Aug-2026)

0/3 (0%)

$7.06 (54.56%)

Buy Since 19-Mar-2024

$38

$26 (216.67%)

$41

4 months 11 days ago
(02-Jun-2026)

0/4 (0%)

$25.71 (209.19%)

Buy Since 21-May-2026

$45

$36.66 (439.57%)

$75

4 months 12 days ago
(01-Jun-2026)

0/2 (0%)

$30.49 (210.13%)

Buy Since 05-Oct-2023

$40

$31.66 (379.62%)

$50

4 months 12 days ago
(01-Jun-2026)

0/8 (0%)

$25.49 (175.67%)

Show more analysts

Please expand the browser size to see the chart

Which stock is Colleen Kusy most bullish on?

Potential upside of $106.97 has been obtained for ARGX (ARGENX NV ADR)

Which stock is Colleen Kusy most reserved on?

Potential downside of $22.46 has been obtained for OCUL (OCULAR THERAPEUTIX)

What Year was the first public recommendation made by Colleen Kusy?

On 2021
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?